ICICI Prudential Nifty Pharma ETF-Growth

About ICICI Prudential Nifty Pharma ETF-Growth

ICICI Prudential Nifty Pharma ETF-Growth is a equity mutual fund scheme of ICICI Prudential Mutual Fund. Launched on October 23, 2026, it is currently managed by Nishit Patel, Ashwini Jemin Bharucha and Venus Ahuja. The fund has an expense ratio of --% with an overall AUM (Assets Under Management) of ₹-- Cr.

ICICI Prudential Nifty Pharma ETF is mandated to invest at least 80 per cent of its assets in the shares of pharmaceutical and healthcare companies. Being passively managed, it replicates the portfolio of its chosen benchmark index. The fund allows minimum lumpsum investment of ₹1 and minimum SIP of ₹--.

Suitability

Pharma funds are suitable for investors:

• Wanting a small, supporting exposure to the pharmaceutical and healthcare sector
• Aiming for long term wealth creation
• With a 7+ year investment horizon, who can withstand the sharper swings of a concentrated portfolio

Note:

• Most investors can skip these funds and stick to diversified equity funds instead
• If you choose to invest, do so only through SIP
• Being passively managed, the fund replicates the portfolio of its chosen benchmark index